Registration Questions? **Please note we have pricing tiers based on ticket availability. Ticket prices will increase once we sell out of the current pricing tier. We cannot redeem a lower price once ...
Key updates to include advances made in the on-going clinical trial for INTASYL siRNA lead product candidate PH-762 Mr. Robert Bitterman, President and CEO of Phio Pharmaceuticals, will deliver an ...
Chris has 25+ years of experience in advancing biomedical technologies. He is Regional Innovation Officer for the MDM2 Consortium in Phoenix and Managing Director of Xcellerant Ventures, Arizona’s ...
The blood-brain-barrier is both a vital defence and a formidable obstacle. It protects the brain from toxic substances that circulate in the blood, but limits the delivery of drugs that could be used ...
Drexel University has signed a landmark lease selecting Gattuso Development Partners’ and Vigilant Holdings’ best-in-class life science development, 3201 Cuthbert Street, as the future home for its ...
Vietnam Investment Review on MSN
Hong Kong Life Sciences Scholarship cultivates future leaders
HONG KONG SAR - Media OutReach Newswire - 5 January 2026 - Amid Hong Kong's rising prominence as a hub for life sciences talent, the Hong Kong Life Sciences Society (HKLSS) is stepping up its efforts ...
PHOENIXVILLE, Pa., Sept. 19, 2024 /PRNewswire/ -- PleoPharma, Inc., a privately held company focused on cannabis related health issues, announced today that their CEO, Ginger Constantine, MD, ...
We used to say data is the new oil. In commercial life sciences, context has become oxygen. AI can read millions of pages, extract structure from chaos and turn scattered trial data, clinical notes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results